Basic Information
RNALocate ID: | RLID:11002634 |
RNA Symbol: | hsa-miR-148b-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-148b |
RNA ID: | miRBase:MIMAT0000759 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002065 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002066 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11002627 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002628 | Exosome | Brain tissue | 23382797 |
RLID:11002629 | Exosome | Plasma | 23663360 |
RLID:11002630 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002631 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11002632 | Microvesicle | Plasma | 19951903 |
RLID:11002633 | Microvesicle | Plasma | 23077538 |
RLID-D:11000133 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Mast cells|Tongue tissue | |
RLID-D:11000436 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-148b-3p | Splenic marginal zone lymphoma | MNDR-E-MI-16098 |
MNDR | hsa-miR-148b-3p | Oral squamous cell carcinoma | MNDR-E-MI-16099 |
MNDR | hsa-miR-148b-3p | Medulloblastoma | MNDR-E-MI-16100 |
MNDR | hsa-miR-148b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-16101 |
MNDR | hsa-miR-148b-3p | Lymphoma | MNDR-E-MI-16102 |
MNDR | hsa-miR-148b-3p | Lymphoma non-hodgkin | MNDR-E-MI-16103 |
MNDR | hsa-miR-148b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-16104 |
MNDR | hsa-miR-148b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-16105 |
MNDR | hsa-miR-148b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-16106 |
MNDR | hsa-miR-148b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-16107 |
MNDR | hsa-miR-148b-3p | Breast cancer luminal | MNDR-E-MI-16108 |
MNDR | hsa-miR-148b-3p | Dermatomyositis | MNDR-E-MI-16109 |
MNDR | hsa-miR-148b-3p | Prostate cancer | MNDR-E-MI-16110 |
MNDR | hsa-miR-148b-3p | Gastric cancer | MNDR-E-MI-16111 |
MNDR | hsa-miR-148b-3p | Gastric lymphoma | MNDR-E-MI-16112 |
MNDR | hsa-miR-148b-3p | Alzheimer disease | MNDR-E-MI-16113 |
MNDR | hsa-miR-148b-3p | Intracranial aneurysm | MNDR-E-MI-16114 |
MNDR | hsa-miR-148b-3p | Dysautonomia familial | MNDR-E-MI-16115 |
MNDR | hsa-miR-148b-3p | Leukemia | MNDR-E-MI-16116 |
MNDR | hsa-miR-148b-3p | Huntington disease | MNDR-E-MI-16117 |
MNDR | hsa-miR-148b-3p | Chorea | MNDR-E-MI-16118 |
MNDR | hsa-miR-148b-3p | Cardiovascular disease | MNDR-E-MI-16119 |
MNDR | hsa-miR-148b-3p | Lung cancer | MNDR-E-MI-16120 |
MNDR | hsa-miR-148b-3p | Fragile x syndrome | MNDR-E-MI-16121 |
MNDR | hsa-miR-148b-3p | Parkinson disease | MNDR-E-MI-16122 |
MNDR | hsa-miR-148b-3p | Breast cancer | MNDR-E-MI-16123 |
MNDR | hsa-miR-148b-3p | Pancreatic cancer | MNDR-E-MI-16124 |
MNDR | hsa-miR-148b-3p | Melanoma | MNDR-E-MI-16125 |
MNDR | hsa-miR-148b-3p | Gaucher disease | MNDR-E-MI-16126 |
MNDR | hsa-miR-148b-3p | Colon cancer | MNDR-E-MI-16127 |
MNDR | hsa-miR-148b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-16128 |
MNDR | hsa-miR-148b-3p | Hematologic cancer | MNDR-E-MI-16129 |
MNDR | hsa-miR-148b-3p | Iga glomerulonephritis | MNDR-E-MI-16130 |
MNDR | hsa-miR-148b-3p | Carcinoma ductal breast | MNDR-E-MI-16131 |
MNDR | hsa-miR-148b-3p | Glioblastoma | MNDR-E-MI-16132 |
MNDR | hsa-miR-148b-3p | Glioma | MNDR-E-MI-16133 |
MNDR | hsa-miR-148b-3p | Nemaline myopathy | MNDR-E-MI-16134 |
MNDR | hsa-miR-148b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-16135 |
MNDR | hsa-miR-148b-3p | Osteosarcoma | MNDR-E-MI-16136 |
MNDR | hsa-miR-148b-3p | Liposarcoma | MNDR-E-MI-16137 |
MNDR | hsa-miR-148b-3p | Meningioma | MNDR-E-MI-16138 |
MNDR | hsa-miR-148b-3p | Lung squamous cell carcinoma | MNDR-E-MI-16139 |
MNDR | hsa-miR-148b-3p | Lung adenocarcinoma | MNDR-E-MI-16140 |
MNDR | hsa-miR-148b-3p | Thyroid carcinoma | MNDR-E-MI-16141 |
MNDR | hsa-miR-148b-3p | Bladder urothelial carcinoma | MNDR-E-MI-16142 |
MNDR | hsa-miR-148b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-16143 |
MNDR | hsa-miR-148b-3p | Carcinoma renal cell | MNDR-E-MI-16144 |
MNDR | hsa-miR-148b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-16145 |
MNDR | hsa-miR-148b-3p | Cholangiocarcinoma | MNDR-E-MI-16146 |
MNDR | hsa-miR-148b-3p | Liver cirrhosis | MNDR-E-MI-16147 |
MNDR | hsa-miR-148b-3p | Lung small cell carcinoma | MNDR-E-MI-16148 |
MNDR | hsa-miR-148b-3p | Synovial sarcoma | MNDR-E-MI-16149 |
MNDR | hsa-miR-148b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-16150 |
MNDR | hsa-miR-148b-3p | Fibromyalgia | MNDR-E-MI-16151 |
MNDR | hsa-miR-148b-3p | Breast invasive carcinoma | MNDR-E-MI-16152 |
MNDR | hsa-miR-148b-3p | Early hepatocellular carcinoma | MNDR-E-MI-16153 |
MNDR | hsa-miR-148b-3p | Rheumatoid arthritis | MNDR-E-MI-16154 |
MNDR | hsa-miR-148b-3p | Hodgkin lymphoma | MNDR-E-MI-16155 |
MNDR | hsa-miR-148b-3p | Tonsil cancer | MNDR-E-MI-16156 |
MNDR | hsa-miR-148b-3p | Neuromyelitis optica | MNDR-E-MI-16157 |
MNDR | hsa-miR-148b-3p | Skin cutaneous melanoma | MNDR-E-MI-16158 |
MNDR | hsa-miR-148b-3p | Skin melanoma | MNDR-E-MI-16159 |
MNDR | hsa-miR-148b-3p | Acute myelocytic leukemia | MNDR-E-MI-16160 |
MNDR | hsa-miR-148b-3p | Gastrointestinal stromal tumor | MNDR-E-MI-16161 |
MNDR | hsa-miR-148b-3p | Colorectal cancer | MNDR-E-MI-16162 |
MNDR | hsa-miR-148b-3p | Nasopharynx carcinoma | MNDR-E-MI-16163 |
MNDR | hsa-miR-148b-3p | Nasopharyngeal cancer | MNDR-E-MI-16164 |
MNDR | hsa-miR-148b-3p | Prostatic neoplasms | MNDR-E-MI-16165 |
MNDR | hsa-miR-148b-3p | Epstein-barr virus infections | MNDR-E-MI-16166 |
MNDR | hsa-miR-148b-3p | Stroke lacunar | MNDR-E-MI-16167 |
MNDR | hsa-miR-148b-3p | High grade dysplastic nodule | MNDR-E-MI-16168 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACACB | Homo sapiens | RR00032414 |
TOP